Sweden, March 18 -- The European Investment Bank (EIB) has signed its first pre-IPO advisory agreement to help a European growth company prepare for access to public capital markets. The support is provided through the InvestEU Advisory Hub and aims to strengthen the ability of innovative European companies to grow and remain in Europe as they scale.The agreement supports Swedish biotechnology company Anocca, based in Sodertalje, which develops next-generation T-cell immunotherapies for cancer. T-cell immunotherapy is a form of treatment that uses a patient's own immune cells, engineered to recognise and attack cancer cells more effectively.The advisory support will help the company prepare for a potential future stock-market listing by str...